Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nutritional Supplement
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : University of Calgary
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 25, 2024
Lead Product(s) : Nutritional Supplement
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : University of Calgary
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Igy Supplement
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : IGY Immune Technologies & Life Sciences Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessing the Safety of an IGY Supplement on the Gut Microbiome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 22, 2024
Lead Product(s) : Igy Supplement
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : IGY Immune Technologies & Life Sciences Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Milk
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 01, 2024
Lead Product(s) : Milk
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : LALLEMAND HEALTH SOLUTIONS
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 19, 2024
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : LALLEMAND HEALTH SOLUTIONS
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Probiotic
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Calgary | Lallemand Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Dietary Intervention Detection in the Small Intestine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 28, 2020
Lead Product(s) : Probiotic
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Calgary | Lallemand Health Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable